The Impact of Respiratory Syncytial Virus (RSV) on Vulnerable Populations

Summary for Physicians: RSV Overview

RSV is a common, seasonal virus causing lower respiratory tract infections, especially bronchiolitis and pneumonia. It poses significant risks to vulnerable groups, such as infants (particularly those who are premature), older adults, and those with chronic conditions or immunosuppression. While often mild, RSV can lead to severe illness and hospitalization in high-risk populations. Preventive measures, including vaccines and monoclonal antibodies, are key to reducing its impact.